Détail de la notice
Titre du Document
Precipitating factors in lymphedema : Myths and realities
Auteur(s)
ROCKSON S. G.
Corporation(s) du ou des auteurs
American Cancer Society New York, NY USA (Commanditaire)
Résumé
BACKGROUND. Lymphedema is an all too common occurrence following breast carcinoma therapy. Despite its prevalence, the predisposing factors to the development of this secondary form of lymphedema remain poorly understood. METHODS. Several studies have addressed these questions and are reviewed here. RESULTS. Treatment factors that appear to predispose to the late, subjective appearance of lymphedema include the extent of axillary surgery and exposure to high dose axillary radiotherapy, particularly when combined with surgical clearance of the axilla. Other pertinent patient factors may include the presence of hypertension and exposure to airline travel. Clinical features unrelated to the risk of lymphedema development include patient age; drug therapy; time interval to presentation, surgery, or radiotherapy to the breast; total dose of radiation; and menopausal status. The potential importance of concomitant venous abnormalities in these patients is worthy of consideration. CONCLUSIONS. Breast carcinoma-related secondary lymphedema is an important subjective and functional problem for affected patients. Additional research into the predisposing factors to this common problem is likely to foster enhanced patient education and to produce more efficacious measures to control this disease.
Editeur
Wiley-Liss
Type du document
Conférence : American Cancer Society Workshop on Breast Cancer Treatment-Related Lymphedema, New York, New York, USA, 1997-02-20
Identifiant
ISSN : 0008-543X CODEN : CANCAR
Source
Cancer A. 1998, vol. 83, SUP2, pp. 2814-2816 [bibl. : 9 ref.]
Langue
Anglais
Pour les membres de la communauté du CNRS, ce document est autorisé à la reproduction à titre gratuit.
Pour les membres des communautés hors CNRS, la reproduction de ce document à titre onéreux sera fournie sous réserve d’autorisation du Centre Français d’exploitation du droit de Copie.

Pour bénéficier de nos services (strictement destinés aux membres de la communauté CNRS (Centre National de la Recherche Scientifique), de l'ESR français (Enseignement Supérieur et Recherche), et du secteur public français & étranger) :